RecruitingNCT06839300

The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study


Sponsor

AO Foundation, AO Spine

Enrollment

260 participants

Start Date

Feb 9, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

To determine the accuracy of serum NF-L and GFAP levels (ie the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D) a group of patients who suffer traumatic spinal fracture and/or dislocation of the spinal column but without neurologic injury will be enrolled as non-SCI spine trauma control participants.


Eligibility

Min Age: 19 Years

Inclusion Criteria12

  • Age ≥ 19 years
  • Blunt (non-penetrating) traumatic SCI
  • Baseline neurologic impairment deemed "complete" (AIS grade A) or "incomplete" (AIS grade B, C, or D) based on clinical history/examination and/or diagnostic imaging
  • Bony spinal level involvement between C0 and L1, inclusive
  • Ability to have initial blood sample drawn within 24 hours of injury
  • Treated either surgically or non-surgically
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures
  • Age ≥ 19 years
  • Traumatic spinal fracture and/or dislocation between C0 and L1 (inclusive) without SCI
  • Treated either surgically or nonsurgically
  • Ability to have initial blood sample drawn within 24 hours of injury
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures

Exclusion Criteria8

  • Penetrating SCI (eg, gunshot, stab)
  • Previous SCI
  • Isolated spinal injury below L1
  • Isolated radiculopathy without fracture
  • Isolated cauda equina injury
  • Patients with known diagnosis of multiple sclerosis
  • Preexisting thromboembolic disease or coagulopathy (disorders related to blood clotting), such as hemophilia or von Willebrand disease
  • Patients who in the investigator's opinion will not be compliant with the study procedures and patients who have any other conditions/injuries that in the investigator's opinion would render the study procedures dangerous

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Prince of Wales Hospital

Sydney, Randwick NSW, Australia

Cajuru University Hospital

Curitiba, Paraná, Brazil

Clinica Alemana de Santiago

Santiago, Vitacura, Chile

Charité Berlin

Berlin, Germany

Sri Balaji Action Medical Institute

New Delhi, India

MIddlemore Hospital

Auckland, Otahuhu, New Zealand

King's College Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06839300


Related Trials